Evan Roberts Sells 16,005 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 16,005 shares of the stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $30.00, for a total value of $480,150.00. Following the completion of the sale, the chief operating officer now owns 748,302 shares in the company, valued at approximately $22,449,060. The trade was a 2.09 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Evan Roberts also recently made the following trade(s):

• On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total value of $294,475.68.
• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The shares were sold at an average price of $27.31, for a total value of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total value of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total value of $76,450.53.

Phreesia Stock Down 1.2 %

Shares of PHR opened at $29.64 on Thursday. The firm has a market cap of $1.72 billion, a PE ratio of -20.16 and a beta of 0.96. The company’s fifty day moving average is $27.14 and its two-hundred day moving average is $23.77. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $30.53. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same quarter last year, the firm posted ($0.58) EPS. The business’s revenue for the quarter was up 16.6% compared to the same quarter last year. Analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms recently commented on PHR. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price objective on shares of Phreesia in a report on Tuesday, December 10th. Truist Financial increased their target price on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. KeyCorp increased their target price on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and increased their price target for the stock from $24.00 to $32.00 in a report on Wednesday, January 8th. Finally, Robert W. Baird dropped their target price on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Thirteen research analysts have rated the stock with a buy rating, According to MarketBeat, Phreesia currently has an average rating of “Buy” and a consensus price target of $31.15.

Hedge Funds Weigh In On Phreesia

A number of hedge funds have recently made changes to their positions in PHR. Versor Investments LP purchased a new stake in Phreesia during the 3rd quarter worth $694,000. Zacks Investment Management acquired a new position in shares of Phreesia in the 3rd quarter valued at about $631,000. State Street Corp boosted its stake in Phreesia by 7.1% during the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after purchasing an additional 88,517 shares during the period. Wesbanco Bank Inc. boosted its stake in Phreesia by 76.9% during the 4th quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock valued at $1,157,000 after purchasing an additional 20,000 shares during the period. Finally, Barclays PLC boosted its stake in Phreesia by 83.6% during the 3rd quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after purchasing an additional 43,225 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.